Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.6.0.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Sep. 30, 2016
Sep. 30, 2015
REVENUES    
Neurometric Services $ 85,100 $ 100,100
Cost of neurometric services revenue 5,500 4,900
Research 53,700 92,000
Product development 740,500 691,800
Sales and marketing 522,000 347,900
General and administrative 2,530,200 1,613,300
Total operating expenses 3,851,900 2,749,900
OPERATING LOSS (3,766,800) (2,649,800)
OTHER INCOME (EXPENSE):    
Interest expense, net (2,721,500) (257,400)
Gain (loss) on extinguishment of debt 572,300 (630,000)
(Loss) gain on derivative liabilities (34,600) 162,800
Finance fees (20,000)
Other miscellaneous income 306,700
Legal settlement expense (275,000)
Total other expense (2,172,100) (724,600)
LOSS BEFORE PROVISION FOR INCOME TAXES (5,938,900) (3,374,400)
Provision for income taxes 2,000 5,000
NET LOSS $ (5,940,900) $ (3,379,400)
BASIC AND DILUTED LOSS PER SHARE:    
From operations (in dollars per share) $ (9.26) $ (6.64)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
Basic and Diluted (in shares) 641,844 509,066